Single-Dose
Phase I and Pharmacokinetic Trial of Perillyl Alcohol (POH)
as a Chemopreventive for Breast Cancer. G.T. Budd, P.J. Elson,
K.K. Chan, J.M. Snyder, M.J. Ellis, S. Banerjee, D. McLain,
E. Hawk, R. Ganapathi. Taussig Cancer Center, Cleveland Clinic
Foundation, Cleveland, OH; The Ohio State University, Columbus,
OH; Georgetown University, Washington, DC; National Cancer
Institute, Bethesda, MD.